retatrutide mechanism of action triple agonist glp-1 gip glucagon LY3437943, a novel glucagon, GIP, and receptor for glycemic control and weight loss: From discovery to clinical proof concept From Obesity to Metabolic Health:
Description
ME-T: Methodology, Visualization, Formal Analysis, Investigation, Writing original draft, Writing review and editing
It was reported that GLP-1R was expressed in colonic mucosal nerve fibers and showed increased expression in biopsies from individuals with IBS [55] (Fig
doi: 10.1093/ajcn/77.3.605
The current labeling continues to downplay the gastrointestinal issues being reported by users
